BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2649468)

  • 1. Keynote address: hypoxic cell radiosensitizers: where next?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):987-93. PubMed ID: 2649468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF; Ward R; Workman P; Bleehen NM
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG; Russo A; Gamson J; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic cell radiosensitizers: expectations and progress in drug development.
    Coleman CN
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):323-9. PubMed ID: 3156109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
    Murayama C; Mori T
    Gan No Rinsho; 1990 Oct; 36(13):2249-54. PubMed ID: 2147449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokinetics.
    Newman HF; Bleehen NM; Workman P
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1113-6. PubMed ID: 2943709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.
    Brown JM; Yu NY
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1207-12. PubMed ID: 6236184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF; Bleehen NM; Ward R; Workman P
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C; Mori T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitizers and protectors in radiotherapy.
    Brown JM
    Cancer; 1985 May; 55(9 Suppl):2222-8. PubMed ID: 2983876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
    Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitizers: rationale and potential.
    Brown JM
    Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
    De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
    Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
    Weinmann M; Welz S; Bamberg M
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application in radiation therapy of substances which modify cellular radiation response.
    Chapman JD; Urtasun RC
    Cancer; 1977 Jul; 40(1 Suppl):484-8. PubMed ID: 195712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical radiosensitizers in cancer therapy.
    Shenoy MA; Singh BB
    Cancer Invest; 1992; 10(6):533-51. PubMed ID: 1422891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Tumor Hypoxia Radiosensitization Via Electron Paramagnetic Resonance Oxygen Imaging (EPROI).
    Rickard AG; Mowery YM; Bassil A; Rouse DC; Williams NT; Charity T; Belloni R; Crouch B; Ramanujam N; Stevenson D; Castillo R; Blocker S; Epel B; Kotecha M; Palmer GM
    Mol Imaging Biol; 2024 Jun; 26(3):435-447. PubMed ID: 37721686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modifiers of cancer treatment.
    Coleman CN; Bump EA; Kramer RA
    J Clin Oncol; 1988 Apr; 6(4):709-33. PubMed ID: 3282035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.